NEW YORK–( BUSINESS WIRE )–Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PixarBio Corporation (OTCQX:PXRB) resulting from allegations that PixarBio may have issued materially misleading business information to the investing public.

On January 23, 2017, the SEC announced the temporary suspension of trading in the securities of PixarBio “because the market for the security appears to reflect manipulative or deceptive activities and because of questions regarding the accuracy of assertions by PixarBio in press releases and its Form S-1 concerning, among other things: (1) the company’s business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees; and (3) the company’s current and prospective development efforts.”

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by PixarBio investors. If you purchased shares of PixarBio before January 23, 2017 please visit the firm’s website at http://www.rosenlegal.com/cases-1034.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected] .

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.